Lund OsteoArthritis Division - Molecular marker research group
61 – 70 of 170
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Efficacy and cost-effectiveness of Stem Cell injections for symptomatic relief and strUctural improvement in people with Tibiofemoral knee OsteoaRthritis : Protocol for a randomised placebo-controlled trial (the SCUlpTOR trial)
(
- Contribution to journal › Article
-
Mark
Is there a reason to challenge our current practice in children’s forearm fractures?
(
- Contribution to journal › Article
-
Mark
Placebo comparator group selection and use in surgical trials : The aspire project including expert workshop
(
- Contribution to journal › Article
-
Mark
Importance of patellofemoral and tibiofemoral cartilage lesions on trajectory of self-reported outcomes in patients at high risk of knee OA : 4–6 years follow-up of patients undergoing meniscal surgery
(
- Contribution to journal › Article
-
Mark
Early-stage symptomatic osteoarthritis of the knee — time for action
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Wild-goose chase, no predictable patient subgroups who benefit from meniscal surgery : patient-reported outcomes of 641 patients 1 year after surgery
(
- Contribution to journal › Article
-
Mark
Juvenile idiopathic arthritis patients have a distinct cartilage and bone biomarker profile that differs from healthy and knee-injured children
(
- Contribution to journal › Article
-
Mark
The role of cartilage glycosaminoglycan structure in gagCEST
(
- Contribution to journal › Article
-
Mark
Molecular and imaging biomarkers of local inflammation at 2 years after anterior cruciate ligament injury do not associate with patient reported outcomes at 5 years
(
- Contribution to journal › Article
-
Mark
Improving osteoarthritis care by digital means - Effects of a digital self-management program after 24- or 48-weeks of treatment
(
- Contribution to journal › Article